Obese, Overweight
Conditions
Brief summary
This study will test the effectiveness of two distinct treatments for weight loss: 1. Motivational Interviewing 2. Nutritional Counseling. These treatments will be compared to Treatment as Usual. Participants will be recruited through local primary care offices.
Interventions
5 sessions of motivational interviewing over a period of 3 months.
5 sessions of nutritional counseling over a period of 3 months.
Participants will be encouraged to continue their care with their primary care physician.
Sponsors
Study design
Eligibility
Inclusion criteria
* BMI 25-55 * Daily access to internet and phone
Exclusion criteria
* Co-existing physical and/or psychiatric conditions that require more significant treatment (e.g., bipolar disorder, psychotic illnesses), and/or require more intensive treatment or hospitalization (e.g., suicidality, severe mood disorders) * Meets criteria for current substance abuse or dependence * Currently receiving psychiatric, psychological, behavioral, or pharmacologic treatment that is known to affect weight or eating * Pregnant, breastfeeding, or plans to become pregnant during the treatment period * Cardiac disease, including ischemic heart disease, congestive heart failure, conduction abnormalities, or a history of heart attack * Serious neurologic illnesses (e.g., seizure history) or medical illnesses (e.g., impaired hepatic or renal function) * Uncontrolled diabetes, thyroid conditions, or hypertension
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body Weight in Pounds. | 1.5 months after treatment start (Baseline) | Body weight lost in pounds measured 1.5 months after first treatment session. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Motivational Interviewing Motivational Interviewing: 5 sessions of motivational interviewing over a period of 3 months. | 30 |
| Nutritional Counseling Nutritional Counseling: 5 sessions of nutritional counseling over a period of 3 months. | 29 |
| Treatment as Usual Treatment as usual with primary care physician: Participants will be encouraged to continue their care with their primary care physician. | 30 |
| Total | 89 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Withdrawal by Subject | 2 | 2 | 1 |
Baseline characteristics
| Characteristic | Motivational Interviewing | Nutritional Counseling | Treatment as Usual | Total |
|---|---|---|---|---|
| Age, Continuous | 47.07 years STANDARD_DEVIATION 9.97 | 48.93 years STANDARD_DEVIATION 11.59 | 47.77 years STANDARD_DEVIATION 10.05 | 47.9 years STANDARD_DEVIATION 10.5 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 8 Participants | 3 Participants | 7 Participants | 18 Participants |
| Race (NIH/OMB) More than one race | 3 Participants | 4 Participants | 2 Participants | 9 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 19 Participants | 22 Participants | 21 Participants | 62 Participants |
| Sex: Female, Male Female | 24 Participants | 20 Participants | 24 Participants | 68 Participants |
| Sex: Female, Male Male | 6 Participants | 9 Participants | 6 Participants | 21 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 30 | 0 / 30 | 0 / 30 |
| serious Total, serious adverse events | 0 / 30 | 0 / 29 | 0 / 30 |
Outcome results
Body Weight in Pounds.
Body weight lost in pounds measured 1.5 months after first treatment session.
Time frame: 1.5 months after treatment start (Baseline)
Population: Intent-to-treat data are presented, with the last observation carried forward, and outliers beyond 3 standard deviations replaced with highest recorded value within the 3 standard deviation range.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Motivational Interviewing | Body Weight in Pounds. | -3.1 pounds | Standard Deviation 4.6 |
| Nutritional Counseling | Body Weight in Pounds. | -3.4 pounds | Standard Deviation 5.2 |
| Treatment as Usual | Body Weight in Pounds. | 0.1 pounds | Standard Deviation 3.5 |
Body Weight in Pounds.
Body weight lost in pounds measured 3 months after first treatment session.
Time frame: 3 months after treatment start (Baseline)
Population: Intent-to-treat data are presented, with the last observation carried forward, and outliers beyond 3 standard deviations replaced with highest recorded value within the 3 standard deviation range.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Motivational Interviewing | Body Weight in Pounds. | -3.3 pounds | Standard Deviation 6.5 |
| Nutritional Counseling | Body Weight in Pounds. | -4.9 pounds | Standard Deviation 6.1 |
| Treatment as Usual | Body Weight in Pounds. | -0.4 pounds | Standard Deviation 6.2 |
Body Weight in Pounds.
Body weight lost in pounds measured 6 months after first treatment session (3 month follow-up after active treatment ends).
Time frame: 6 months after treatment start (Baseline)
Population: Intent-to-treat data are presented, with the last observation carried forward, and outliers beyond 3 standard deviations replaced with highest recorded value within the 3 standard deviation range.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Motivational Interviewing | Body Weight in Pounds. | -2.6 pounds | Standard Deviation 8.7 |
| Nutritional Counseling | Body Weight in Pounds. | -5.7 pounds | Standard Deviation 9 |
| Treatment as Usual | Body Weight in Pounds. | 0.4 pounds | Standard Deviation 7.2 |